The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAKR.L Share News (AKR)

  • There is currently no data for AKR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Akers Biosciences Issues Default Notice To Shareholder ChubeWorkx

Mon, 11th May 2015 08:49

LONDON (Alliance News) - Akers Biosciences Inc said Monday it has served a notice of default to shareholder ChubeWorkx Guernsey Ltd due to it failing to pay on time two instalments under a promissory note, and has filed a suit in the District Court of New Jersey in the US to stop ChubeWorkx from selling its shares in the company.

ChubeWorkx has a 9.97% interest in Akers.

ChubeWorkx issued the promissory note in the aggregate amount of USD1.48 million at the end of 2014. The note was payable in sixty equal instalments, and pays interest of 5% per year. Although Akers did receive the March 1 and April 1 instalments, it has served a notice of default for ChubeWorkx as it failed to pay either instalment in the time period required by the note.

Akers now says ChubeWorkx must immediately satisfy all monies owed and outstanding on the note, amounting to USD1.37 million.

In the event of a default, Akers has the right to require ChubeWorkx to transfer all of its shares back to the company, so Akers said it has filed the suit against ChubeWorkx to enforce this remedy and prevent ChubeWorkx from selling its shares to any third parties.

Shares in Akers are untraded Monday morning. It last closed at 299.00 pence.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
4 Nov 2014 16:15

UK AGM, EGM Calendar - Week Ahead

Read more
4 Nov 2014 08:21

UK MORNING BRIEFING: Legal & General, Imperial Tobacco Start Strongly

Read more
4 Nov 2014 06:13

UK AGM, EGM Calendar - Week Ahead

Read more
3 Nov 2014 16:09

UK AGM, EGM Calendar - Week Ahead

Read more
23 Oct 2014 12:30

Akers Biosciences Inks Joint Venture Deal With Hainin Savy In China

Read more
9 Sep 2014 16:02

MARKET COMMENT: London Ends Mixed Amid Boost From Production Data

Read more
9 Sep 2014 11:46

Akers Biosciences Signs USD864,000 Tri-Cholesterol "Check" Sales Deal

Read more
15 Aug 2014 07:39

UK MORNING BRIEFING: Miners Lead Broad-Based London Gains

Read more
15 Aug 2014 06:46

Akers Biosciences Appoints Co-Chairman

Read more
12 Aug 2014 10:42

Akers Biosciences Posts Wider Loss But Rise In Flagship Product Sales

Read more
28 Jul 2014 10:20

Akers Inks Feasibility Study Deal With Konica For Heart Attack Tests

Read more
17 Jul 2014 10:18

Akers Biosciences Breath Device Granted Patent

Read more
25 Jun 2014 13:28

REPEAT: Akers Biosciences Inks Distribution Agreement With Medline Industries

Read more
25 Jun 2014 12:40

UK MIDDAY BRIEFING: AbbVie Sets Out Case For Shire Acquisition

Read more
25 Jun 2014 12:10

Akers Biosciences secures US distribution for heparin test

Shares in Akers Biosciences were higher on news that it had secured a major distribution agreement in the US for its test to determine if patients will have a reaction to blood thinner heparin. The company's PIFA Heparin/PF4 and PIFA PLUSS PF4 rapid tests with Medline Industries, which it said was

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.